{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:23:36Z","timestamp":1787271816533,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-1127301C, TCVGH-1127302D, TCVGH-YM1120110, TCVGH-1137310C, TCVGH-1137319C, TCVGH-1137302D, TCVGH-1127304B, TCVGH-1137302B, and TCVGH-1143903B"],"award-info":[{"award-number":["TCVGH-1127301C, TCVGH-1127302D, TCVGH-YM1120110, TCVGH-1137310C, TCVGH-1137319C, TCVGH-1137302D, TCVGH-1127304B, TCVGH-1137302B, and TCVGH-1143903B"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-1127301C, TCVGH-1127302D, TCVGH-YM1120110, TCVGH-1137310C, TCVGH-1137319C, TCVGH-1137302D, TCVGH-1127304B, TCVGH-1137302B, and TCVGH-1143903B"],"award-info":[{"award-number":["TCVGH-1127301C, TCVGH-1127302D, TCVGH-YM1120110, TCVGH-1137310C, TCVGH-1137319C, TCVGH-1137302D, TCVGH-1127304B, TCVGH-1137302B, and TCVGH-1143903B"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC -111-2634-F-A49-014, NSTC-111-2218-E-039-001, and NSTC-111-2314-B-075A-003-MY3"],"award-info":[{"award-number":["NSTC -111-2634-F-A49-014, NSTC-111-2218-E-039-001, and NSTC-111-2314-B-075A-003-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["40-05-GMM and AS-GC-110-MD0"],"award-info":[{"award-number":["40-05-GMM and AS-GC-110-MD0"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-54386-3","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T19:45:15Z","timestamp":1781034315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic polymorphisms associated with therapeutic response and adverse effects to methotrexate in Taiwanese patients with rheumatoid arthritis: a real-world, hospital-based study"],"prefix":"10.1038","volume":"16","author":[{"given":"Ta-Wei","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-Cheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Mao","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"1","key":"54386_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","volume":"6","author":"Q Guo","year":"2018","unstructured":"Guo, Q. et al. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 6 (1), 15 (2018).","journal-title":"Bone Res."},{"issue":"4","key":"54386_CR2","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/cells9040880","volume":"9","author":"Y-J Lin","year":"2020","unstructured":"Lin, Y-J., Anzaghe, M. & Sch\u00fclke, S. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells 9 (4), 880 (2020).","journal-title":"Cells"},{"key":"54386_CR3","unstructured":"Gabriel, S. E. & MD MSC:, M. S. Epidemiology of, risk factors for, and possible causes of rheumatoid arthritis. Section Editor: Ravinder N Maini, BA, MB BChir, FRCP, FMedSci, FRSDeputy Editor: Paul L Romain, MD. In.; (2018)."},{"key":"54386_CR4","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00296-017-3726-1","volume":"37","author":"TM Hunter","year":"2017","unstructured":"Hunter, T. M. et al. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004\u20132014. Rheumatol. Int. 37, 1551\u20131557 (2017).","journal-title":"Rheumatol. Int."},{"key":"54386_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40744-020-00252-1","volume":"8","author":"H Almoallim","year":"2021","unstructured":"Almoallim, H. et al. A review of the prevalence and unmet needs in the management of rheumatoid arthritis in Africa and the Middle East. Rheumatol. Ther 8, 1\u201316 (2021).","journal-title":"Rheumatol. Ther"},{"key":"54386_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00296-012-2411-7","volume":"33","author":"C-F Kuo","year":"2013","unstructured":"Kuo, C.-F. et al. Rheumatoid arthritis prevalence, incidence, and mortality rates: A nationwide population study in Taiwan. Rheumatol. Int. 33, 355\u2013360 (2013).","journal-title":"Rheumatol. Int."},{"key":"54386_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2020.100522","volume":"17","author":"CK Porter","year":"2020","unstructured":"Porter, C. K. et al. Cohort profile of a US military population for evaluating pre-disease and disease serological biomarkers in rheumatoid and reactive arthritis: Rationale, organization, design, and baseline characteristics. Contemp. Clin. Trials Commun. 17, 100522 (2020).","journal-title":"Contemp. Clin. Trials Commun."},{"issue":"7","key":"54386_CR8","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.3390\/diagnostics12071560","volume":"12","author":"HY Abdallah","year":"2022","unstructured":"Abdallah, H. Y. et al. Pharmacogenomics of methotrexate pathway in rheumatoid arthritis patients: approach toward personalized medicine. Diagnostics 12 (7), 1560 (2022).","journal-title":"Diagnostics"},{"issue":"6","key":"54386_CR9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1159\/000493390","volume":"27","author":"J Bullock","year":"2019","unstructured":"Bullock, J. et al. Rheumatoid arthritis: a brief overview of the treatment. Med. Principles Pract. 27 (6), 501\u2013507 (2019).","journal-title":"Med. Principles Pract."},{"issue":"3","key":"54386_CR10","first-page":"437","volume":"37","author":"JL Pablos","year":"2018","unstructured":"Pablos, J. L. et al. Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: The randomised JUST-ACT study. Clin. Exp. Rheumatol. 37(3), 437\u2013444 (2018).","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"54386_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","volume":"16","author":"BN Cronstein","year":"2020","unstructured":"Cronstein, B. N. & Aune, T. M. Methotrexate and its mechanisms of action in inflammatory arthritis. Nat. Rev. Rheumatol. 16(3), 145\u2013154 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"54386_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/tpj.2011.42","volume":"13","author":"S Owen","year":"2013","unstructured":"Owen, S. et al. MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: Analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms. Pharmacogenomics J. 13(2), 137\u2013147 (2013).","journal-title":"Pharmacogenomics J."},{"key":"54386_CR13","doi-asserted-by":"crossref","unstructured":"Eektimmerman, F. et al. Genome-wide association study of methotrexate-induced liver injury in rheumatoid arthritis patients. Clin. Pharmacol. Ther. 113(4), 916\u2013923 (2023).","DOI":"10.1002\/cpt.2858"},{"key":"54386_CR14","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S350417","author":"H Cen","year":"2022","unstructured":"Cen, H. et al. Associations between genetic polymorphisms within transporter genes and clinical response to methotrexate in Chinese rheumatoid arthritis patients: A pilot study. Pharmacogenomics Pers. Med. https:\/\/doi.org\/10.2147\/PGPM.S350417 (2022).","journal-title":"Pharmacogenomics Pers. Med."},{"key":"54386_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.865267","volume":"13","author":"K Wei","year":"2022","unstructured":"Wei, K. et al. Biomarkers to predict DMARDs efficacy and adverse effect in rheumatoid arthritis. Front. Immunol. 13, 865267 (2022).","journal-title":"Front. Immunol."},{"issue":"20","key":"54386_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20205023","volume":"20","author":"Y Bedoui","year":"2019","unstructured":"Bedoui, Y. et al. Methotrexate an old drug with new tricks. Int. J. Mol. Sci. 20(20), 5023 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"54386_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1075603","volume":"13","author":"SS Kolan","year":"2022","unstructured":"Kolan, S. S. et al. Identification of SNPs associated with methotrexate treatment outcomes in patients with early rheumatoid arthritis. Front. Pharmacol. 13, 1075603 (2022).","journal-title":"Front. Pharmacol."},{"issue":"15","key":"54386_CR18","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2217\/pgs-2021-0064","volume":"22","author":"JK Sundbaum","year":"2021","unstructured":"Sundbaum, J. K. et al. Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate. Pharmacogenomics 22 (15), 973\u2013982 (2021).","journal-title":"Pharmacogenomics"},{"issue":"6","key":"54386_CR19","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.3390\/pharmaceutics15061661","volume":"15","author":"FC Ceballos","year":"2023","unstructured":"Ceballos, F. C. et al. Pharmacogenetic sex-specific effects of methotrexate response in patients with rheumatoid arthritis. Pharmaceutics 15 (6), 1661 (2023).","journal-title":"Pharmaceutics"},{"issue":"3","key":"54386_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11030832","volume":"11","author":"R Choi","year":"2022","unstructured":"Choi, R., Lee, S. G. & Lee, E. H. Intraindividual changes in rheumatoid factor and anti-cyclic citrullinated peptide antibody tests in Korean patients visiting local clinics and hospitals. J. Clin. Med. 11(3), 832 (2022).","journal-title":"J. Clin. Med."},{"issue":"4","key":"54386_CR21","first-page":"387","volume":"19","author":"G Mostafa-Hedeab","year":"2020","unstructured":"Mostafa-Hedeab, G., Elborai, Y. & Ebid, G. T. A. Effects of Methylene Tetrahydro Folate Reductase Gene Polymorphisms on Methotrexate Toxicity in Egyptian Pediatric Acute Lymphocytic Leukaemia Patients. Iran. J. Pharm. Research: IJPR. 19 (4), 387 (2020).","journal-title":"Iran. J. Pharm. Research: IJPR"},{"issue":"2","key":"54386_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2217\/14622416.9.2.235","volume":"9","author":"C-T Fan","year":"2008","unstructured":"Fan, C-T., Lin, J-C. & Lee, C-H. Taiwan Biobank: a project aiming to aid Taiwan\u2019s transition into a biomedical island. Pharmacogenomics 9 (2), 235\u2013246 (2008).","journal-title":"Pharmacogenomics"},{"issue":"1","key":"54386_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-021-00178-9","volume":"6","author":"C-Y Wei","year":"2021","unstructured":"Wei, C.-Y. et al. Genetic profiles of 103,106 individuals in the Taiwan Biobank provide insights into the health and history of Han Chinese. Npj. Genom. Med. 6(1), 10 (2021).","journal-title":"Npj. Genom. Med."},{"issue":"1","key":"54386_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1124\/jpet.106.101774","volume":"318","author":"M Vlaming","year":"2006","unstructured":"Vlaming, M. et al. Carcinogen and anticancer drug transport by MRP2 in vivo: Studies using MRP2 (ABCC2) knockout mice. J. Pharmacol. Exp. Ther. 318(1), 319\u2013327 (2006).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"54386_CR25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1124\/jpet.108.140475","volume":"327","author":"Y Kitamura","year":"2008","unstructured":"Kitamura, Y., Hirouchi, M., Kusuhara, H., Schuetz, J. D. & Sugiyama, Y. Increasing systemic exposure of methotrexate by active efflux mediated by multidrug resistance-associated protein 3 (mrp3\/abcc3). J. Pharmacol. Exp. Ther. 327 (2), 465\u2013473 (2008).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"54386_CR26","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1158\/1078-0432.CCR-08-2940","volume":"15","author":"ML Vlaming","year":"2009","unstructured":"Vlaming, M. L. et al. Functionally overlapping roles of ABCG2 (BCRP1) and ABCC2 (MRP2) in the elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate in vivo. Clin. Cancer Res. 15(9), 3084\u20133093 (2009).","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"54386_CR27","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41397-020-0168-z","volume":"20","author":"M Grk","year":"2020","unstructured":"Grk, M. et al. Analysis of association of ADORA 2 A and ADORA 3 polymorphisms genotypes\/haplotypes with efficacy and toxicity of methotrexate in patients with Rheumatoid arthritis. Pharmacogenomics J. 20 (6), 784\u2013791 (2020).","journal-title":"Pharmacogenomics J."},{"issue":"3","key":"54386_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/phar.2779","volume":"43","author":"M Zobeck","year":"2023","unstructured":"Zobeck, M. et al. Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 43(3), 205\u2013214 (2023).","journal-title":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"},{"key":"54386_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00085","volume":"4","author":"G Hask\u00f3","year":"2013","unstructured":"Hask\u00f3, G. & Cronstein, B. Regulation of inflammation by adenosine. Front. Immunol. 4, 85 (2013).","journal-title":"Front. Immunol."},{"key":"54386_CR30","first-page":"400","volume":"24","author":"L Rath-Wolfson","year":"2006","unstructured":"Rath-Wolfson, L. et al. IB-MECA, an A. Clin. Exp. Rheumatol. 24, 400\u2013406 (2006).","journal-title":"Clin. Exp. Rheumatol."},{"issue":"10","key":"54386_CR31","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/FPC.0b013e328343dd93","volume":"21","author":"TS Mikkelsen","year":"2011","unstructured":"Mikkelsen, T. S. et al. PharmGKB summary: Methotrexate pathway. Pharmacogenet. Genomics 21(10), 679\u2013686 (2011).","journal-title":"Pharmacogenet. Genomics"},{"key":"54386_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-019-1014-8","volume":"8","author":"A Gast","year":"2019","unstructured":"Gast, A. & Mathes, T. Medication adherence influencing factors\u2014an (updated) overview of systematic reviews. Syst. reviews. 8, 1\u201317 (2019).","journal-title":"Syst. reviews"},{"key":"54386_CR33","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S165404","author":"LL Zullig","year":"2018","unstructured":"Zullig, L. L. et al. The new landscape of medication adherence improvement: Where population health science meets precision medicine. Patient Prefer. Adherence https:\/\/doi.org\/10.2147\/PPA.S165404 (2018).","journal-title":"Patient Prefer. Adherence"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54386-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54386-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54386-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T23:33:15Z","timestamp":1787268795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54386-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54386"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54386-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All individual in this study afforded written informed consent, and the research protocol was duly permitted by the ethics committee of the Institutional Review Board at TCVGH (IRB No. SF19153A).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26274"}}